Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
This is a natural progression for the company as it continues to increase the impact of its nanonization technology and expand its major pharma client base in the US, it states.
A new Head of US sales
The establishment of Nanoform USA Inc. follows the recent appointment of Sally Langa as Head of US Sales. Sally brings 30 years of valuable commercial experience in Pharma, having held senior positions at Catalent Pharma, Patheon and Halo Pharmaceutical.
The expansion also coincides with increasing interest in Nanoform’s technology within the US marketplace and the company’s application for GMP status at its Finnish site, which is expected to further fuel demand for Nanoform’s proprietary CESS technology, the company states.
“We are tremendously excited to have officially established our presence in the US with a wholly owned subsidiary. This comes as a natural next step for our company as we continue to expand the reach of our nanonization technology,” says Edward Hæggström, Nanoform CEO.